Allos Therapeutics, Inc. Reports Second Quarter 2009 Financial Results

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq: ALTH) today reported results for the second quarter of 2009. For the three months ended June 30, 2009, the Company reported a net loss of $16.8 million, or ($0.19) per share. This compares to a net loss of $11.8 million, or ($0.16) per share, for the second quarter of 2008. For the six months ended June 30, 2009, the Company reported a net loss of $32.0 million, or ($0.38) per share, compared to a net loss of $23.8 million, or ($0.34) per share, for the same period last year. For the six months ended June 30, 2009, net cash used in operating activities was $25.6 million. Cash, cash equivalents and investments in marketable securities as of June 30, 2009 were $105.2 million.